The launch of LYFE, a digital therapeutics solution, has been announced by Lupin Digital Health, a fully-owned subsidiary of the major global pharmaceutical company Lupin.
It is the only evidence-based holistic heart care program available in India. It can help cardiac patients live longer and reduces their risk of heart attacks. Through doctor-connected online and offline modules, LYFE, created by eminent Indian cardiologists, assists people in improving their heart health. Approved by FDA and CE, this wearable technology records vital signs and alerts caretakers and doctors about emergencies.
LYFE's user-friendly interface provides 24-hour emergency and ambulance help, and prescription reminders. Furthermore, it provides professional assistance in the form of devoted care managers, health coaches, and nutritionists. It is an end-to-end solution for cardiac patients, in accordance with protocols designed by their treating cardiologists.
The digital therapeutics platform LYFE leverages the power of human intelligence and AI/ML to improve patient outcomes by enhancing doctor-patient collaboration, constantly monitoring health vitals, boosting patient awareness, and improving therapy compliance.
LYFE enables seamless monitoring of patient vitals and intervenes to assist and guide patients during emergencies. Coupled with a host of features and designed with inputs from leading cardiologists, LYFE improves the quality of life of patients and reduces the stress and anxiety of their caregivers.